Q
Qin Feng
Researcher at Shanghai University
Publications - 52
Citations - 1440
Qin Feng is an academic researcher from Shanghai University. The author has contributed to research in topics: Fatty liver & Medicine. The author has an hindex of 16, co-authored 44 publications receiving 1045 citations. Previous affiliations of Qin Feng include University at Buffalo & Women & Children's Hospital of Buffalo.
Papers
More filters
Journal ArticleDOI
Roles of Chlorogenic Acid on Regulating Glucose and Lipids Metabolism: A Review
TL;DR: This review addresses current studies investigating the roles of CGA in glucose and lipid metabolism and indicates that CGA exerts many biological properties, including antibacterial, antioxidant, and anticarcinogenic activities.
Journal ArticleDOI
Gut Microbial Dysbiosis Is Associated with Altered Hepatic Functions and Serum Metabolites in Chronic Hepatitis B Patients.
Jing Wang,Yang Wang,Xu Zhang,Jiaqi Liu,Qianpeng Zhang,Yu Zhao,Jinghua Peng,Qin Feng,Jian-ye Dai,Shu-jun Sun,Yufeng Zhao,Liping Zhao,Yongyu Zhang,Yongyu Zhang,Yi-Yang Hu,Menghui Zhang +15 more
TL;DR: In this article, the compositional and functional changes in the gut microbiota in early stage chronic hepatitis B (CHB) patients suggest the potential contributions of gut microbiota to the progression of CHB, and thus provide new insight into gut microbiota-targeted interventions to improve the prognosis of this disease.
Journal ArticleDOI
Structural changes of gut microbiota in a rat non-alcoholic fatty liver disease model treated with a Chinese herbal formula.
Xiaochen Yin,Jinghua Peng,Liping Zhao,Liping Zhao,Yunpeng Yu,Xu Zhang,Ping Liu,Qin Feng,Yi-Yang Hu,Xiaoyan Pang +9 more
TL;DR: The results revealed that the bacterial profiles of HFD-induced rats could be modulated by theCHF, and differences in microbiota composition provided a basis for further understanding the pharmacological mechanism of the CHF.
Journal ArticleDOI
Potential Biological Effects of (-)-Epigallocatechin-3-gallate on the Treatment of Nonalcoholic Fatty Liver Disease
TL;DR: The objectives of this paper are to review and discuss the currently known targets, signaling pathways and roles of EGCG that interfere with NAFLD pathogenesis, then providing additional experimental evidence and the foundation for the further studies and clinical applications of E GCG in the prevention and treatment ofNAFLD.
Journal ArticleDOI
Protective effect of genistein on nonalcoholic fatty liver disease (NAFLD).
TL;DR: A review of the potential role of genistein (GE) in the treatment and prevention of NAFLD and some of the currently known targets and signalling pathways of GE inNAFLD are summarized.